YOOZOO-GAMES
YOOZOO Games is limbering up for an epic gaming marathon next month, as gamers all over the world get ready to turn their on-screen efforts into meals; all in support of the World Food Programme’s (WFP) fight against hunger in some of the world’s most vulnerable regions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190728005030/en/
Gaming fans will get to enjoy exclusive gameplay features and events during the week-long initiative; by joining in they will be helping to raise crucial funding for the World Food Programme. The premise is simple: the more you play, the more YOOZOO donates. #GTarcadeHungerHeroes is a call from GTarcade to experience, to share and to make more people aware of the existence of hunger — participating in fun, charitable activities that will aid WFP in their mission to reach a world with zero hunger.
YOOZOO Games said “For 10 years we’ve been incredibly fortunate to bring simple joy to millions of people around the world, through video games. The support we’ve received from our loyal fans has allowed us to support a variety of important causes. This year, we want to push the boundaries even further and help provide urgent support to those who truly need it the most.”
For the GTarcade marathon, YOOZOO has set up a team in the World Food Programme app, ShareTheMeal. All funds raised in the #GTarcade team will go towards operations supported by the ShareTheMeal app.
Check out the trailer for the gaming marathon here: https://youtu.be/15x-C39V0M0
There are three ways that you can get involved with GTarcade’s Hunger Heroes event and help raise money in the fight against hunger:
1) Tweet a picture of your smile meal with the hashtag #GTarcadeHungerHeroes. For every tweet you send, YOOZOO games will donate one meal ($0.50) to WFP.
2) Join in the GTarcade gaming marathon. From August 12th to 18th, for every hour of livestream play YOOZOO Games will donate one meal to the WFP. As an added ‘marathon bonus’ — 2 hours of livestream play will be also be rewarded with $10 in-game coins, while over 12 hours will yield $100 dollars’ worth of in-game coins.
3) Get exclusive in-game features by joining the Hunger Heroes Gaming Marathon. Collect four in-game treasure chests or wings, which can be exchanged for one meal donation to the World Food Programme. Players will then get to see their favourite characters turning those items into meals in the #GTarcade team in ShareTheMeal.
For more details about the event visit the official page here: https://pact.gtarcade.com/en/hungerHeroes.html?m
Join in with the conversation on Twitter and Facebook with the hashtag #GTarcadeHungerHeroes
Join the gaming marathon on GTarcade: https://www.gtarcade.com/
Join the YOOZOO ShareTheMeal team here: https://bit.ly/2JMuWSw
About YOOZOO Games
YOOZOO Games is a global entertainment company specializing in game development and distribution. The company is headquartered in Shanghai with offices in London, Berlin, Hong Kong, Singapore, and other major cities. Since its founding in 2009, YOOZOO has launched a multitude of highly successful products such as Legacy of Discord – Furious Wings and League of Angels, and has forged a strong global distribution network.
Official Site http://www.yoozoo.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20190728005030/en/
Link:
Social Media:
https://www.facebook.com/SaintSeiyaSEA/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom